TrialCancer immunology research2014

CD4 T cells require ICOS-mediated PI3K signaling to increase T-Bet expression in the setting of anti-CTLA-4 therapy.

Hong Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.